Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 9;15(2):420.
doi: 10.3390/cancers15020420.

Patient Reported Outcomes and Measures in Children with Rhabdomyosarcoma

Marloes van Gorp  1 , Martha A Grootenhuis  1 , Anne-Sophie Darlington  2 , Sara Wakeling  3 , Meriel Jenney  4 , Johannes H M Merks  1 , Lisa Lyngsie Hjalgrim  5 , Madeleine Adams  4
Affiliations

Patient Reported Outcomes and Measures in Children with Rhabdomyosarcoma

Marloes van Gorp et al. Cancers (Basel). .

Abstract

In addition to optimising survival of children with rhabdomyosarcoma (RMS), more attention is now focused on improving their quality of life (QOL) and reducing symptoms during treatment, palliative care or into long-term survivorship. QOL and ongoing symptoms related to the disease and its treatment are outcomes that should ideally be patient-reported (patient-reported outcomes, PROs) and can be assessed using patient-reported outcome measures (PROMS). This commentary aims to encourage PRO and PROM use in RMS by informing professionals in the field of available PROMs for utilisation in paediatric RMS and provide considerations for future use in research and clinical practice. Despite the importance of using PROMs in research and practice, PROMs have been reported scarcely in paediatric RMS literature so far. Available literature suggests lower QOL of children with RMS compared to general populations and occurrence of disease-specific symptoms, but a lack of an RMS-specific PROM. Ongoing developments in the field include the development of PROMs targeted at children with RMS specifically and expansion of PROM evaluation within clinical trials.

Keywords: adverse events; childhood cancer; patient-reported outcome measures; patient-reported outcomes; quality of life; rhabdomyosarcoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Haverman L., Limperg P.F., Young N.L., Grootenhuis M.A., Klaassen R.J. Paediatric health-related quality of life: What is it and why should we measure it? Arch. Dis. Child. 2017;102:393–400. doi: 10.1136/archdischild-2015-310068. - DOI - PubMed
    1. Skapek S.X., Ferrari A., Gupta A.A., Lupo P.J., Butler E., Shipley J., Barr F.G., Hawkins D.S. Rhabdomyosarcoma. Nat. Rev. Dis. Prim. 2019;5:1. doi: 10.1038/s41572-018-0051-2. - DOI - PMC - PubMed
    1. Schoot R.A., Slater O., Ronckers C.M., Zwinderman A.H., Balm A.J., Hartley B., van den Brekel M.W., Gupta S., Saeed P., Gajdosova E. Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment. Eur. J. Cancer. 2015;51:1424–1434. doi: 10.1016/j.ejca.2015.02.010. - DOI - PubMed
    1. Ferrer F.A., Isakoff M., Koyle M.A. Bladder/Prostate Rhabdomyosarcoma: Past, Present and Future. J. Urol. 2006;176:1283–1291. doi: 10.1016/j.juro.2006.06.019. - DOI - PubMed
    1. Kazak A.E., Abrams A.N., Banks J., Christofferson J., DiDonato S., Grootenhuis M.A., Kabour M., Madan-Swain A., Patel S.K., Zadeh S., et al. Psychosocial Assessment as a Standard of Care in Pediatric Cancer. Pediatr. Blood Cancer. 2015;62((Suppl. S5)):S426–S459. doi: 10.1002/pbc.25730. - DOI - PubMed

LinkOut - more resources